Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise ...

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

A rapid-fire reversal from the Food and Drug Administration has injected even more uncertainty into what was already a wild ...

LifeVantage's shares surged 11% on the successful GLP-1 weight-management trial ... need to be suppressed to the same degree post-weight loss after 6 to 12 months, for example.

The quest for effective and safe weight loss solutions has long been a focus of medical research. In recent years, a novel approach involving GLP-1 injections has emerged as a potential game ...

The study involved 425 participants. Of these, 183 received surgery, while 242 received GLP-1 diabetes drugs, which also promote weight loss. Participants were followed for a median of 5.8 years.

WeightWatchers CEO Sima Sistani is leaving the company after two and a half years. During that time, the company has radically altered its business model to stay competitive in the Ozempic era.

BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs, like Wegovy, have been approved for kids 12 and up and the number of ...

The soon to be released product system activates production of the GLP-1 hormone to not only support weight management, but also metabolic health and long-term well-being. * † For further ...